Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity

Last updated: August 27, 2023
Sponsor: Alexandria University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Nerve Injury

Treatment

exposure to organophosphates

Clinical Study ID

NCT06021262
0107603
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of this observational study is to answer the following questions in individuals with acute and chronic exposure to organophosphates. The main questions to be addressed are

  1. What are the prognostic values of neuroinflammatory markers?

  2. What are the genotoxic effects of organophosphates?

  3. what are the changes occurring in the levels of traditional oxidative stress and inflammatory markers?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • For the control group: healthy individuals without previous exposure toorganophosphates, with the specified age limits.
  • For the acute exposure group: patients with acute exposure to organophosphates, withthe specified age limits
  • For the chronic exposure group: patients with chronic exposure to organophosphates,with the specified age limits No restrictions on comorbidities in the three groups except those mentioned under ExclusionCriteria

Exclusion

Exclusion Criteria:

  • Pediatric patients.
  • Patients with neurological diseases (Parkinsonism, epilepsy, Alzheimer's disease,etc.)
  • Patients who does not meet the inclusion criteria.

Study Design

Total Participants: 90
Treatment Group(s): 1
Primary Treatment: exposure to organophosphates
Phase:
Study Start date:
August 01, 2023
Estimated Completion Date:
January 31, 2024

Study Description

This is a cross-sectional study that aims to assess the possible prognostic value of markers of neuroinflammation and nerve damage in patients with acute and chronic exposure to organophosphate pesticides by conducting a full proteomic and metabolomic profile. The possible genotoxic effect of common organophosphate pesticides will be studied as well. This will be conducted in parallel to the assessment of traditional markers of inflammation and oxidative stress. The target populations are patients with acute and chronic exposure to organophosphates with a total estimated number of 90 including individuals assigned to the control group with matched age and gender.

Connect with a study center

  • Alexandria Main University Hospital

    Alexandria,
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.